BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Aljabban J, Rohr M, Syed S, Khorfan K, Borkowski V, Aljabban H, Segal M, Mukhtar M, Mohammed M, Panahiazar M, Hadley D, Spengler R, Spengler E. Transcriptome changes in stages of non-alcoholic fatty liver disease. World J Hepatol 2022; 14(7): 1382-1397 [PMID: 36158924 DOI: 10.4254/wjh.v14.i7.1382]
URL: https://www.wjgnet.com/1948-5182/full/v14/i7/1382.htm
Number Citing Articles
1
Natacha Cerisier, Bryan Dafniet, Anne Badel, Olivier Taboureau. Linking chemicals, genes and morphological perturbations to diseasesToxicology and Applied Pharmacology 2023; 461: 116407 doi: 10.1016/j.taap.2023.116407
2
Ruiyi Liu, Yan Sun, Dong Di, Xiyuan Zhang, Boran Zhu, Haoxin Wu. PI3K/AKT/SERBP-1 pathway regulates Alisma orientalis beverage treatment of atherosclerosis in APOE −/− high-fat diet mice Pharmaceutical Biology 2023; 61(1): 473 doi: 10.1080/13880209.2023.2168020
3
Miguel D. Ferrer, Clara Reynés, Margalida Monserrat-Mesquida, Magdalena Quetglas-Llabrés, Cristina Bouzas, Silvia García, David Mateos, Miguel Casares, Cristina Gómez, Lucía Ugarriza, Josep A. Tur, Antoni Sureda, Antoni Pons. Polyunsaturated and Saturated Oxylipin Plasma Levels Allow Monitoring the Non-Alcoholic Fatty Liver Disease Progression to Severe StagesAntioxidants 2023; 12(3): 711 doi: 10.3390/antiox12030711
4
Aylin Acun, Letao Fan, Ruben Oganesyan, Korkut M. Uygun, Heidi Yeh, Martin L. Yarmush, Basak E. Uygun. Effect of Donor Age and Liver Steatosis on Potential of Decellularized Liver Matrices to be used as a Platform for iPSC‐Hepatocyte CultureAdvanced Healthcare Materials 2024;  doi: 10.1002/adhm.202302943
5
Divyavani Gowda, Chandra Shekhar, Siddabasave Gowda B. Gowda, Yifan Chen, Shu-Ping Hui. Crosstalk between Lipids and Non-Alcoholic Fatty Liver DiseaseLivers 2023; 3(4): 687 doi: 10.3390/livers3040045